|
Market Closed -
Nasdaq
04:00:00 2026-01-14 pm EST
|
5-day change
|
1st Jan Change
|
|
85.60 USD
|
+1.57%
|
 |
-12.45%
|
-6.56%
|
|
Jan. 09 |
HealthEquity Shares Fall After Goldman Sachs Downgrade
|
MT
| |
Jan. 09 |
Goldman Sachs Downgrades HealthEquity to Sell From Neutral, Adjusts Price Target to $89 From $113
|
MT
| |
Dec. 09 |
Barclays Initiates HealthEquity With Overweight Rating, $118 Price Target
|
MT
| |
Dec. 05 |
Deutsche Bank Adjusts Price Target on HealthEquity to $120 From $117, Maintains Buy Rating
|
MT
| |
Nov. 13 |
BMO Capital Initiates Coverage on HealthEquity With Market Perform Rating
|
MT
| |
25-09-05 |
Deutsche Bank Lifts Price Target on HealthEquity to $117 From $115, Keeps Buy Rating
|
MT
| |
25-09-03 |
RBC Lifts Price Target HealthEquity to $110 From $109, Keeps Outperform Rating
|
MT
| |
25-09-02 |
Health-savings account manager HealthEquity Q2 revenue beats estimates
|
RE
| |
25-08-28 |
RBC Lowers Price Target on HealthEquity to $109 From $117, Keeps Outperform Rating
|
MT
| |
25-06-06 |
Barrington Adjusts Price Target on HealthEquity to $125 From $112, Maintains Outperform Rating
|
MT
| |
25-06-05 |
Deutsche Bank Adjusts HealthEquity Price Target to $115 From $98, Maintains Buy Rating
|
MT
| |
25-06-05 |
Analyst recommendations: Microsoft, Nvidia, Visa, Dollar Tree, Roblox…
|  | |
25-06-04 |
HealthEquity Shares Rise After RBC Price Target Raise
|
MT
| |
25-06-04 |
RBC Raises Price Target on HealthEquity to $117 From $112, Keeps Outperform Rating
|
MT
| |
25-05-22 |
RBC Raises Price Target on HealthEquity to $112 From $105, Keeps Outperform Rating
|
MT
| |
25-03-25 |
Raymond James Upgrades HealthEquity to Strong Buy From Outperform, Adjusts Price Target to $115 From $120
|
MT
| |
25-03-25 |
Raymond James Upgrades HealthEquity to Strong Buy From Outperform, Price Target is $115
|
MT
| |
25-03-20 |
Deutsche Bank Lowers Price Target on HealthEquity to $98 From $108, Keeps Buy Rating
|
MT
| |
25-01-14 |
Deutsche Bank Adjusts HealthEquity Price Target to $108 From $103, Maintains Buy Rating
|
MT
| |
24-12-10 |
Barrington Research Cuts HealthEquity Price Target to $112 From $120, Maintains Outperform Rating
|
MT
| |
24-12-10 |
RBC Raises Price Target on HealthEquity to $105 From $100, Keeps Outperform Rating
|
MT
| |
24-12-04 |
Mizuho Initiates HealthEquity at Outperform With $126 Price Target
|
MT
| |
24-12-02 |
Analyst recommendations: Cloudflare, Toast, Netflix, Robinhood, HSBC...
| | |
24-09-19 |
HealthEquity Positioned to Weather Fed Rate Cuts, RBC Says
|
MT
| |
24-09-19 |
RBC Raises Price Target on HealthEquity to $100 From $92, Keeps Outperform Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
